Gottlieb predicts "broad immunity" among kids
Dr. Scott Gottlieb says the "brisk" pace of vaccinations among 5- to 11-year-olds should lead to "broad immunity" from COVID-19.
Watch CBS News
Dr. Scott Gottlieb says the "brisk" pace of vaccinations among 5- to 11-year-olds should lead to "broad immunity" from COVID-19.
Pfizer says results from its preliminary drug trial are "extraordinary." CBS News correspondent Jonathan Vigliotti reports on one man's urgent call for Americans to get vaccinated and wear masks. Then, ER physician and Harvard professor Dr. Ali Raja joins CBSN's Lana Zak for the latest on COVID-19.
U.S. companies added 531,000 jobs last month and the unemployment rate dropped to 4.6%, a sign the economy is healing from the pandemic. But as Americans reenter the workforce, some are finding it hard to land a job. Manuel Bojorquez reports.
Colin Powell's blood cancer left him vulnerable to COVID-19. Dr. David Agus explains how a treatment could soon protect millions of others with compromised immunity from the worst effects of the coronavirus.
Every school-age child in the U.S. is now eligible for COVID-19 shots after Pfizer's mini dose received the green light from the Centers for Disease Control and Prevention. Janet Shamlian takes a look.
Aspiring nurses have not been dissuaded from pursing their dreams amid widespread burnout during the pandemic. At Temple University, nursing school applications far outnumber available spots. Mola Lenghi takes a look.
Green Bay Packers quarterback Aaron Rodgers is sidelined after testing positive for COVID-19. There are questions about whether he violated the NFL's COVID protocols. Vladimir Duthiers reports.
Children ages 5 to 11 are now eligible for a lower-dose version of Pfizer's COVID-19 vaccine, after the CDC issued its recommendation on Tuesday. Dr. Julie Morita, the executive vice president of the Robert Wood Johnson Foundation, joined CBSN to discuss the latest coronavirus headlines.
It took months for electronic speakers to travel from a factory in China to a music store in New York amid a global supply chain crisis. Ramy Inocencio and Carter Evans followed their journey.
The Centers for Disease Control and Prevention is on the verge of reccomending the Pfizer COVID-19 vaccination for children between the ages of 5 and 11. Dr. Julie Morita, executive vice president at the Robert Wood Johnson Foundation, joined CBSN to discuss the vaccination and what this means for parents.
The pandemic led many women to leave the workforce, but a sign company in Washington, D.C., is adding more women to its workforce. Kris Van Cleave shares more.
Centers for Disease Control and Prevention advisers voted to recommend Pfizer's COVID-19 vaccine for children as young as 5. Meg Oliver shares more.
A 7-year-old girl who had a heart transplant when she was just 17 days old hopes to pay it forward by enrolling in COVID-19 vaccine clinical trials for children who are immunocompromised. Janet Shamlian shares her story.
It's estimated that by 2023, half a million kids with autism will reach adulthood, which puts a strain on working parents, increasing the demand for adult daycares. But one center in Virginia is facing closure due to the COVID pandemic and the death of its founder from sickle cell anemia. Debra Alfarone has more.
New data shows the number of women seeking a career change jumped a record 54% compared to this time last year. CBS News MoneyWatch reporter Aimee Picchi joins CBSN's Lana Zak to explain why.
The FDA has authorized Pfizer's COVID-19 vaccine for kids aged 5 to 11. Clinical trials found the smaller dose is 91% effective against the virus. Executive vice president of the Robert Wood Johnson Foundation Dr. Julie Morita joined CBSN's Lana Zak to discuss.
The legislation protects employees who do not get vaccinated against COVID-19.
The global supply chain is struggling to recover from the pandemic and its woes are hitting the U.S. economy. New York Times global economics correspondent Peter Goodman joins CBSN's Tanya Rivero for more on the story.
New York City firefighters held a rally against the mayor’s COVID-19 vaccine mandate for city workers. CBS New York’s John Dias reports.
An FDA advisory panel gave a thumbs up to Pfizer's mini-dose COVID-19 vaccine for children as young as 5, and if it clears the final hurdles, the first shots could be delivered next week. Janet Shamlian reports.
Pfizer's COVID-19 vaccine for children is one step closer to being approved after an FDA advisory committee voted unanimously to recommend lower doses of the shot for kids aged 5 to 11. CBS News correspondent Janet Shamlian reports on the panel's decision. Then, Dr. Ben Weston, an associate professor in the department of emergency medicine at the Medical College of Wisconsin, joins CBSN's Elaine Quijano to discuss the latest.
An FDA advisory panel is meeting today to consider if millions of younger children, ages 5 to 11, should be eligible for Pfizer's COVID-19 vaccine. CBS News' Laura Podesta joins CBSN AM with the latest.
FDA advisers are meeting to consider recommending the Pfizer COVID-19 vaccine for kids aged 5 to 11. Meanwhile, Moderna says its data shows a strong immune response in young children from its shot. Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss these latest developments.
Dr. Anthony Fauci said COVID-19 vaccines for children between ages 5 and 11 will likely be available in the first half of November. Mark Strassmann reports.
Several European nations go back into lockdown as new COVID-19 infections surge in the region. Elizabeth Palmer reports.